Drug Clinical Trials List
Drug Clinical Trials List
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial | King Saud Medical City | Ongoing | Colistin | 4 | CCD-AFM-00 | King Saud Medical City (Riyadh) |
| A multicenter, observational, prospective Study of theuse of Valsartan (Tabuvan®) and Valsartan HCTZ (co-Tabuvan®) on adult patients with essentialHypertension in Saudi Arabia | Tabuk Pharmaceuticals | Ongoing | Tabuvan | 4 | T-VAHST | Prince Sultan Military Medical City (Riyadh) |
| Glargine Insulin versus Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition | King Faisal Specialist Hospital & Research Center | Ongoing | Lantus® | 4 | 147 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A randomised blinded placebo controlled trial of hydrocortisone in critically illpatients with septic shock | University of Sydney | Ongoing | HYDROCORTISONE | 4 | GI-CCT3722 | King Fahad Medical City (riyadh), King Khalid University Hospital (Riyadh) |
| Multi-Center Prospective Randomized Controlled Trial of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury | KAIMRC | Ongoing | N/A | 4 | RC11/056 | King Abdulaziz Medical City NG (Riyadh) |
| LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes | Novartis | Ongoing | RANIBIZUMAB | 4 | RFB002A240 | king khaled eye specialist hospital (riyadh) |
| Alx-Mcd-502 A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies | Alexion Pharma International Sàrl. | Completed | N/A | 4 | ALX-MCD-502 | King Fahad Medical City (Riyadh) |
| The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial | King Saud University | Ongoing | Caffeine | 4 | E-15-1484 | King Khalid University Hospital (Riyadh) |
| Effect of heparin 20 u /kg/hr. continuous infusion on central venous catheter related thrombosis in children. | KAIMRC | Ongoing | HEPARIN | 4 | RC12/145 | King Abdulaziz Medical City NG (Riyadh) |
| The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis | Novartis | Ongoing | Fingolimod (Glienya) | 4 | FTY720D2404 | King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh) |